OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 64 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $257,000 | -21.4% | 52,276 | -20.7% | 0.00% | – |
| Q3 2016 | $327,000 | -2.4% | 65,884 | 0.0% | 0.00% | – |
| Q2 2016 | $335,000 | -3.2% | 65,884 | +8.6% | 0.00% | – |
| Q1 2016 | $346,000 | -41.1% | 60,675 | +7.3% | 0.00% | – |
| Q4 2015 | $587,000 | -46.4% | 56,554 | -4.6% | 0.00% | -100.0% |
| Q3 2015 | $1,095,000 | -5.0% | 59,262 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,153,000 | +11.5% | 59,262 | +0.8% | 0.00% | 0.0% |
| Q1 2015 | $1,034,000 | +10.0% | 58,810 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $940,000 | +9.6% | 58,810 | -13.7% | 0.00% | 0.0% |
| Q3 2014 | $858,000 | -23.9% | 68,151 | -5.7% | 0.00% | 0.0% |
| Q2 2014 | $1,128,000 | +19.0% | 72,242 | +0.0% | 0.00% | 0.0% |
| Q1 2014 | $948,000 | -20.9% | 72,208 | -3.1% | 0.00% | 0.0% |
| Q4 2013 | $1,199,000 | +5.5% | 74,538 | +9.2% | 0.00% | 0.0% |
| Q3 2013 | $1,136,000 | +64.4% | 68,268 | -0.5% | 0.00% | 0.0% |
| Q2 2013 | $691,000 | – | 68,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,035,709 | $37,600,000 | 5.29% |
| GREAT POINT PARTNERS LLC | 75,000 | $1,385,000 | 0.55% |
| Hood River Capital Management LLC | 204,653 | $3,780,000 | 0.52% |
| Timpani Capital Management LLC | 69,640 | $1,286,000 | 0.52% |
| RATIONAL ADVISORS LLC | 64,000 | $1,182,000 | 0.48% |
| PIPER SANDLER & CO. | 22,000 | $406,000 | 0.43% |
| PRINCETON CAPITAL MANAGEMENT INC | 34,825 | $643,000 | 0.39% |
| TFS CAPITAL LLC | 101,070 | $1,867,000 | 0.18% |
| FALCON POINT CAPITAL, LLC | 26,557 | $491,000 | 0.18% |
| EAM Investors, LLC | 56,694 | $1,047,000 | 0.17% |